FATE
Fate Therapeutics, Inc. · Healthcare
Chief R, D Officer Bahram Valamehr sold $49K of Fate Therapeutics, Inc.
Sold$49,367
$4.38Price
11,271Shares
−7%Stake
What FATE did after the filing
- The stock from Wed, Jan 10 close, $4.57
- +52.3%
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Feb 23 close.
Traded Tue, Jan 9. Filed Wed, Jan 10, 11:30 AM ET, during the session. Returns use the Jan 10 close and the Feb 23 close. Not investment advice.